High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.2M
$2,233,065
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-10 | $51,806 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -55.7%
2026-03-10
$599,087
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -55.7%
|
2026-03-10 | $599,087 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-09 | $670,200 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -12.8%
2026-03-09
$1,356,072Largex2
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -12.8%
|
2026-03-09 | $1,356,072Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Equity Compensation
|
2025-11-01 | $0 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Sell to CoverΔOwn -25.1%
2025-11-01
$277,905
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Sell to CoverΔOwn -25.1%
|
2025-11-01 | $277,905 | S | Form 4 |